X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (78) 78
humans (75) 75
female (66) 66
obstetrics & gynecology (48) 48
oncology (42) 42
middle aged (34) 34
obstetrics and gynecology (28) 28
cancer (26) 26
adult (22) 22
hematology, oncology and palliative medicine (21) 21
aged (20) 20
ovarian cancer (19) 19
survival (19) 19
analysis (17) 17
chemotherapy (17) 17
neoplasm staging (15) 15
pregnancy (15) 15
kaplan-meier estimate (14) 14
proportional hazards models (14) 14
retrospective studies (14) 14
chemotherapy, adjuvant (12) 12
endometrial cancer (12) 12
metastasis (12) 12
prognosis (12) 12
abridged index medicus (11) 11
cell line, tumor (11) 11
hysterectomy (11) 11
research (11) 11
women (11) 11
ovarian neoplasms - drug therapy (10) 10
cohort studies (9) 9
databases, factual (9) 9
expression (9) 9
ovarian neoplasms - metabolism (9) 9
paclitaxel (9) 9
antineoplastic agents - therapeutic use (8) 8
biochemistry (8) 8
biomarkers (8) 8
multivariate analysis (8) 8
ovarian neoplasms - pathology (8) 8
tumors (8) 8
carcinoma (7) 7
care and treatment (7) 7
chorionic gonadotropin - blood (7) 7
endometrial neoplasms - pathology (7) 7
health aspects (7) 7
investigating or analysing materials by determining theirchemical or physical properties (7) 7
management (7) 7
measuring (7) 7
oncology, experimental (7) 7
ovarian neoplasms - genetics (7) 7
physics (7) 7
prenatal diagnosis (7) 7
proteins (7) 7
research article (7) 7
risk (7) 7
survival rate (7) 7
testing (7) 7
uterine neoplasms - pathology (7) 7
aged, 80 and over (6) 6
article (6) 6
beer (6) 6
chemistry (6) 6
chorionic gonadotropin - urine (6) 6
compositions or test papers therefor (6) 6
condition-responsive control in microbiological orenzymological processes (6) 6
databases (6) 6
enzymology (6) 6
human necessities (6) 6
hygiene (6) 6
measuring or testing processes involving enzymes, nucleicacids or microorganisms (6) 6
medical or veterinary science (6) 6
metallurgy (6) 6
microbiology (6) 6
multidisciplinary sciences (6) 6
mutation or genetic engineering (6) 6
ovarian neoplasms - mortality (6) 6
ovarian neoplasms - therapy (6) 6
preparations for medical, dental, or toilet purposes (6) 6
processes of preparing such compositions (6) 6
specific therapeutic activity of chemical compounds ormedicinal preparations (6) 6
spirits (6) 6
surgery (6) 6
survival analysis (6) 6
vinegar (6) 6
wine (6) 6
adenocarcinoma - pathology (5) 5
adjuvant treatment (5) 5
age (5) 5
binding (5) 5
case report (5) 5
chorionic gonadotropin (5) 5
down syndrome (5) 5
down syndrome - diagnosis (5) 5
drug resistance, neoplasm (5) 5
endometrial neoplasms - mortality (5) 5
endometrial neoplasms - surgery (5) 5
false positive reactions (5) 5
gestational age (5) 5
gynecology (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE, ISSN 0028-0836, 04/2015, Volume 520, Issue 7546, pp. 157 - 157
Journal Article
BMC Cancer, ISSN 1471-2407, 02/2013, Volume 13, Issue 1, pp. 72 - 72
Background: MicroRNAs in solid malignancies can behave as predictors of either good or poor outcome. This is the case with members of the miR-200 family, which... 
Class III beta-tubulin | HuR | Predictive biomarkers | MiR-200c | Ovarian cancer | miR-200c | MARKER | SENSITIVITY | HYPOXIA | PACLITAXEL | ONCOLOGY | RESISTANCE | EXPRESSION | BINDING | III BETA-TUBULIN | Immunohistochemistry | Multivariate Analysis | Adenocarcinoma - pathology | Immunoprecipitation | Paclitaxel - pharmacology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Cytoplasm - metabolism | Drug Resistance, Neoplasm | MicroRNAs - metabolism | Tubulin - genetics | Ovarian Neoplasms - mortality | RNA, Messenger - metabolism | Dose-Response Relationship, Drug | Ovarian Neoplasms - genetics | Tubulin - metabolism | Adenocarcinoma - metabolism | Cell Nucleus - metabolism | Transfection | RNA Interference | Time Factors | Biomarkers, Tumor - metabolism | Female | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacology | Ovarian Neoplasms - metabolism | 3' Untranslated Regions | Binding Sites | Microfluidic Analytical Techniques | Adenocarcinoma - immunology | ELAV Proteins - metabolism | Kaplan-Meier Estimate | Proportional Hazards Models | Cisplatin - pharmacology | Disease-Free Survival | Glucose - deficiency | Adenocarcinoma - therapy | Cell Line, Tumor | Ovarian Neoplasms - therapy | Biomarkers, Tumor - genetics | Cell Proliferation - drug effects | Nanotechnology | Adenocarcinoma - mortality | Ovarian Neoplasms - immunology | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 20, pp. 1905 - 1914
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 145, Issue 1, pp. 9 - 14
Abstract Objectives To determine the cost-effectiveness of dose-dense versus standard intravenous adjuvant chemotherapy for ovarian cancer using results from... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | FALLOPIAN-TUBE | CARBOPLATIN | ONCOLOGY | PACLITAXEL | OBSTETRICS & GYNECOLOGY | Drug Costs | Markov Chains | Peripheral Nervous System Diseases - chemically induced | Hematologic Agents - economics | Blood Transfusion - economics | Humans | Hospitalization - statistics & numerical data | Antineoplastic Agents - administration & dosage | Blood Transfusion - statistics & numerical data | Neoplasms, Glandular and Epithelial - economics | Female | Filgrastim - therapeutic use | Chemotherapy, Adjuvant | Neutropenia - chemically induced | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Paclitaxel - economics | Decision Support Techniques | Hematologic Agents - therapeutic use | Proportional Hazards Models | Anemia - chemically induced | Anemia - therapy | Peripheral Nervous System Diseases - economics | Neutropenia - economics | Antineoplastic Agents - economics | Neutropenia - drug therapy | Randomized Controlled Trials as Topic | Disease-Free Survival | Filgrastim - economics | Administration, Intravenous | Ovarian Neoplasms - economics | Cost-Benefit Analysis | Neoplasms, Glandular and Epithelial - drug therapy | Anemia - economics | Carcinoma, Ovarian Epithelial | Hospitalization - economics | Cost benefit analysis | Analysis | Ovarian cancer | Adjuvant treatment | Cancer | Index Medicus
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2016, Volume 143, Issue 3, pp. 636 - 641
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2016, Volume 143, Issue 3, pp. 472 - 478
Abstract Objective To determine overall survival (OS) and factors associated with OS after pelvic exenteration for uterine cancer. Methods Women with uterine... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Exenteration | Prognosis | Survival | Uterine neoplasms | BIOMARKERS | RECURRENT ENDOMETRIAL CANCER | ONCOLOGY | OUTCOMES | OBSTETRICS & GYNECOLOGY | Multivariate Analysis | Neoplasms, Cystic, Mucinous, and Serous - surgery | Adenocarcinoma - pathology | Lymph Nodes - pathology | Carcinosarcoma - surgery | Uterine Neoplasms - pathology | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Insurance, Health - statistics & numerical data | Protective Factors | Carcinoma, Endometrioid - surgery | Carcinosarcoma - mortality | Sarcoma - mortality | Uterine Neoplasms - mortality | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Databases, Factual | Adenocarcinoma, Clear Cell - surgery | Carcinosarcoma - pathology | Neoplasms, Cystic, Mucinous, and Serous - pathology | Risk Factors | Kaplan-Meier Estimate | Margins of Excision | Proportional Hazards Models | Survival Rate | Tumor Burden | Sarcoma - pathology | Uterine Neoplasms - surgery | Carcinoma, Endometrioid - mortality | Sarcoma - surgery | Pelvic Exenteration | Adenocarcinoma, Clear Cell - pathology | Aged | Neoplasm Staging | Carcinoma, Endometrioid - pathology | Neoplasms, Cystic, Mucinous, and Serous - mortality | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Databases | Research | Oncology, Experimental | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 11524 - 11524
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, pp. e101065 - e101065
Journal Article